noom weight loss glp-1 expands its range with 'microdose' package Noom offers cut-price compounded GLP-1

However, semaglutide starts to come off patent in several countries in early 2026, including India, which is both the worlds largest sugar consumer and also home to approximately 135 million pre-diabetic adults

Understanding Retatrutide: Mechanism and Pharmacology What it is: Retatrutide (LY3437943) is an injectable that activates three metabolic receptors: GLP-1, GIP, and glucagon

Busy lifestyles, daily stress, hormones, genetics, and aging can all contribute to weight gain, but they do not have to control it

Oral medication (pills): Follow instructions from your pharmacist

For CPG / Food and Beverage Manufacturers: Less is more (again): Weve all heard the phrase less is more. However, a trip down the grocery aisle may tell you the opposite

Hepatology (2023)